Abstract-Ventricular arrhythmias are common in both cardiac hypertrophy and failure; cardiac failure in particular is associated with a significant increase in the risk of sudden cardiac death. We studied the electrophysiologic changes in a guinea pig model with aortic banding resulting in cardiac hypertrophy at 4 weeks and progressing to cardiac failure at 8 weeks using whole-cell patch-clamp and biochemical techniques. Action potential durations (APDs) were significantly prolonged in banded animals at 4 and 8 weeks compared with age-matched sham-operated animals. APDs at 50% and 90% repolarization (APD 50 and APD 90 in ms) were the following: 4 week, banded, 208Ϯ51 and 248Ϯ49 (nϭ15); 4 week, sham, 189Ϯ68 and 213Ϯ69 (nϭ16); 8 week, banded, 197Ϯ40 and 226Ϯ40 (nϭ21); and 8 week, sham, 156Ϯ42 and 189Ϯ45 (nϭ22), respectively; PϽ0.05 comparing banded versus sham-operated animals. We observed no significant differences in the K ϩ currents between the 2 groups of animals at 4 and 8 weeks. However, banded animals exhibited a significant increase in Na ϩ and Na ϩ -Ca 2ϩ exchange current densities compared with controls. Furthermore, we have found a significant attenuation in the Ca 2ϩ -dependent inactivation of the L-type Ca 2ϩ current in the banded compared with sham-operated animals, likely as a result of the significant downregulation of the sarcoplasmic reticulum Ca 2ϩ ATPase, which has been documented previously in the heart failure animals. Our data provide an alternate mechanism for APD prolongation in cardiac hypertrophy and failure and support the notion that there is close interaction between Ca 2ϩ handling and action potential profile. (Circ Res. 2000;86:558-570.)
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Key Words: cardiac hypertrophy Ⅲ cardiac failure Ⅲ action potential Ⅲ guinea pig Ⅲ Ca 2ϩ current E ven though ventricular arrhythmias are common in both cardiac hypertrophy and failure, 1,2 cardiac failure in particular is associated with a significant increase in the risk of sudden cardiac death. 3 Indeed, sudden cardiac death is one of the most common causes of death in heart failure patients, occurring with roughly the same frequency as pump failure. The underlying basis for this increase in arrhythmias is not known. Numerous studies have provided evidence using a variety of animal models for cardiac hypertrophy and failure, as well as tissues from human heart failure, that multiple electrophysiological and biochemical alterations occur during hypertrophy and heart failure. Most studies have identified a prolongation in cardiac action potentials. 4 -9 These changes in the repolarization have been found to be associated with reduction of transient outward K ϩ current (I to ) and inward rectifier K ϩ current (I K1 ). 9, 10 There are alterations in sarcoplasmic reticulum (SR) Ca 2ϩ -handling proteins. [11] [12] [13] [14] [15] Finally, the plasma membrane Na ϩ -Ca 2ϩ exchanger is upregulated in some heart failure models. 16, 17 Previous studies of heart failure have shown a downregulation of I to as one of the major causes of action potential prolongation. However, this current (I to ) is absent in guinea pig ventricular myocytes. Nonetheless, there is marked prolongation of action potential duration (APD) in a guinea pig model with cardiac hypertrophy and failure, similar to that in human, rat, dog, and cat, where I to is prominent. 18 Thus, the guinea pig model may provide an additional alternative mechanism for action potential alteration in cardiac hypertrophy and failure.
We investigated the electrophysiologic and biochemical changes in a guinea pig model with cardiac hypertrophy, which reliably progresses to cardiac failure with a predictable time course. In this model, thoracic aortic banding of guinea pigs for 4 weeks produces compensated left ventricular (LV) hypertrophy, which is defined as increased LV mass-to-body mass ratio, normal LV contractile function, and no pulmonary congestion as indexed by the lung-to-body weight ratio. However, after aortic banding for 8 weeks, the decompen-sated phenotype appears as manifested by LV hypertrophy, contractile depression, and pulmonary congestion. Thus, this guinea pig model of thoracic aortic banding provides a continuum from normal to compensated and decompensated hypertrophy with congestive heart failure.
We have identified at least 4 biophysical and biochemical changes associated with cardiac hypertrophy and failure in the guinea pig model, as follows. (1) 
Materials and Methods

Compensated Cardiac Hypertrophy and Failure Model in Guinea Pigs
LV hypertrophy and failure were induced in adult male Charles River guinea pigs (250 to 300 g) by chronic pressure overload using subtotal descending thoracic aortic banding as described. 13 Shamoperated animals underwent the same operation, except that the aorta was not banded.
Electrophysiological Recordings
Single LV myocytes were isolated as previously described. 19 Action potentials were recorded using the perforated patch technique. 20 All other experiments were performed using the conventional whole-cell patch-clamp technique. 21 Action potentials and delayed rectifier K ϩ currents were recorded at 36Ϯ0.5°C, whereas other currents were recorded at room temperature.
Solutions
For action potential recordings, the patch pipettes were backfilled with amphotericin (200 g/mL). Pipette solution contained (in mmol/L) potassium glutamate 120, KCl 25, MgCl 2 1, CaCl 2 
Western Blot Analysis
The relative protein levels of Na ϩ -Ca 2ϩ exchanger were determined from LV homogenates obtained from aortic-banded and shamoperated animals at 4 and 8 weeks using quantitative immunoblot techniques. Equal amounts of protein extract from the 4 groups of animals (50 g/lane) were subjected to electrophoresis as described. 13 The separated proteins were transferred to nitrocellulose membranes. Blots were incubated with a polyclonal antibody for Na ϩ -Ca 2ϩ exchanger (Swant) and in sequential steps with peroxidase-conjugated secondary antibody (goat anti-rabbit IgG, Kirkegaard & Perry Laboratories) and detected by the enhanced chemiluminescent detection system (Amersham Life Science). Relative protein level was determined by normalization to the level of actin, which was used as the internal control.
An expanded Materials and Methods section is available online at http://www.circresaha.org. Figure 1A demonstrates that thoracic aortic banding of guinea pigs for 4 weeks produces a significant increase in LV mass-to-body mass ratio without evidence of pulmonary congestion, as indexed by the lung-to-body weight ratio. In contrast, after aortic banding for 8 weeks, the decompensated phenotype appears as manifest by LV hypertrophy and pulmonary congestion ( Figure 1A ). The documented increase in LV mass at 4 and 8 weeks was found to be associated with cellular hypertrophy. Cell capacitance of 4-and 8-week aortic-banded animals was significantly increased as com- The deterioration in the contractile function in aorticbanded guinea pigs has previously been described in this model. 13 At 4 weeks after aortic banding, there is preservation of LV contractile function; however, after 8 weeks, there is contractile depression associated with pulmonary congestion. Thus, this guinea pig model of thoracic aortic banding provides a continuum from normal to compensated and then to decompensated hypertrophy with congestive heart failure. Figure 1C and 1D are action potentials recorded from isolated cardiac myocytes from hypertrophy and failure animals. The APD measured at 50% and 90% repolarization (APD 50 and APD 90 ) obtained from the hypertrophy and failure animals were significantly prolonged as compared with the age-matched sham-operated animals. These changes were not associated with changes in the resting membrane potentials. To understand the mechanisms for the observed changes in the APD in cardiac hypertrophy and failure animals, we examined the ionic currents and Na ϩ -Ca 2ϩ exchange current.
Results
Validity of the Guinea Pig Model
Duration of Action Potentials Is Markedly
I Kr and I Ks Remain Unchanged During Cardiac Hypertrophy and Failure
Guinea pig ventricular myocytes exhibit 2 components of delayed rectifier K ϩ currents, which are the rapidly activating (I Kr ) and the slowly activating (I Ks ) delayed rectifier K ϩ currents. I Kr can be specifically blocked by the benzenesulfonamide drugs, eg, E4031 or D-sotalol. 24 We measured both components of the K ϩ currents in LV myocytes isolated from banded and shamoperated animals at 4 and 8 weeks after surgery. Depolarizations (2 seconds each) activated an outward current, which grew larger over time ( Figure 2A ). Repolarizations to Ϫ40 mV evoked outward tail currents that decayed gradually. Currents were recorded before and after exposure to 10 mol/L dofetilide, which blocks the I Kr component. 25 The drug-sensitive component (difference current, I Kr ) was obtained by subtraction of the currents recorded in the presence of dofetilide from control records. The drug-sensitive component demonstrates an activation threshold, which is more negative than the druginsensitive component (I Ks ). I Kr does not exhibit any obvious delay in onset and is fully activated during the pulse. In contrast, I Ks is time dependent and shows a more depolarized activation threshold. Figure 2B compares the peak tail currents obtained at Ϫ40 mV after depolarization to various potentials of the drugsensitive (I Kr ) and -insensitive (I Ks ) components. Another feature that is characteristic of the I Kr is evident; the tail current magnitude saturates with increased depolarization ( Figure 2B ). A, Effects of aortic banding on heart, lung, and liver weight. Data are shown as meanϮSEM of heart, lung, and liver weight (in g) per body weight (in kg). At 4 weeks, banded animals showed a significant increase in only heart/body weight ratio (nϭ25 and 26 sham and banded animals at 4 weeks, respectively). In contrast, at 8 weeks, there were significant increases in both the heart/body weight and lung/body weight ratios (nϭ26 and 28 for sham and banded animals at 8 weeks). B, Different underlying repolarizing currents in guinea pig cardiac myocytes. Action potentials recorded from 3 different control cells at 37°C at a stimulation frequency of 0. Data were obtained from 4 different groups of animals, shamoperated and banded animals at 4 and 8 weeks each. We compared the peak I Kr and I Ks current density between the sham and banded animals at 4 and 8 weeks. There was no significant difference in either I Kr or I Ks components between the sham and banded animals at 2 different time points. I Kr and I Ks tail current density measured at Ϫ40 mV after depolarization to ϩ40 mV (in pA/pF) for sham versus banded animals at 4 and 8 weeks were as follows: I Kr , 0.43Ϯ0.14 (nϭ7) versus 0.51Ϯ0.13 (nϭ 8, PϭNS), and 0.52Ϯ 0.09 (nϭ14) versus 0.63Ϯ0.11 (nϭ15, PϭNS); I Ks , 0.49Ϯ0.13 (nϭ7) versus 0.48Ϯ0.04 (nϭ8, PϭNS), and 0.45Ϯ0.08 (nϭ14) versus 0.44Ϯ0.06 (nϭ15, PϭNS).
I K1 Is Unchanged in Cardiac Hypertrophy and Failure
The inward rectifier K ϩ current (I K1 ) is important in maintaining the resting membrane potential and the terminal repolarization phase of the action potential ( Figure 1 ). I K1 current density was measured from the cardiac hypertrophy and failure animals and compared with the age-matched sham-operated controls (Figure 3 ). There were no significant differences in the current density measured from banded animals as compared with sham-operated animals at both 4 and 8 weeks. For example, peak I K1 densities (in pA/pF) elicited from a holding potential of Ϫ40 to Ϫ100 mV were Ϫ8.0Ϯ0.6 (nϭ7), Ϫ11.3Ϯ0.7 (nϭ4), Ϫ9.3Ϯ0.1 (nϭ9), and Ϫ11.0Ϯ0.6 (nϭ5) for sham versus banded at 4 and 8 weeks, respectively (PϭNS).
Na
؉ Current Density Was Significantly Increased in Cardiac Hypertrophy and Failure
Because the shape and duration of action potentials are critically dependent on the underlying inward and outward currents, we next compared the current density of the inward Na ϩ and Ca 2ϩ currents between the banded and the shamoperated animals. Na ϩ currents were carefully examined among the 4 groups of animals under symmetrical recording conditions to reduce the magnitude of the current to ensure adequate voltage control. Currents were activated from a holding potential of Ϫ100 mV. We observed a significant increase in the Na ϩ current density in animals with cardiac hypertrophy and failure compared with age-matched sham- There were no significant changes in the delayed rectifier K ϩ currents in hypertrophy or heart failure animals. Holding potential was set at Ϫ40 mV to inactivate the Na ϩ current and T-type Ca 2ϩ current. Nimodipine (10 mol/L) was used to block the L-type Ca operated animals ( Figure 4) . Peak Na ϩ current density at the test potential of Ϫ35 mV (in pA/pF) was Ϫ22.8Ϯ11.5 (nϭ6) versus Ϫ41.3Ϯ12.4 (nϭ17) (Pϭ0.002), comparing sham and banded animals at 4 weeks. The corresponding values at 8 weeks were Ϫ27.5Ϯ8.1 (nϭ6) versus Ϫ35.7Ϯ5.7 (nϭ9), Pϭ0.03, for sham and banded animals, respectively. The steady-state activation and inactivation of Na ϩ current were similar between the banded and sham-operated animals. The threshold for activation was ϷϪ65 mV and the current peaked near Ϫ35 mV. Figure 4C and 4D shows the normalized conductance versus membrane potential obtained from banded animals compared with age-matched sham-operated controls at 4 and 8 weeks. The relations were well described by a Boltzmann function. There were no significant changes in the steady-state voltage-dependent activation between the sham-operated and banded animals at the 2 different time points (V 1/2 , Ϫ47.1Ϯ0. 19 Figure 4E and 4F, which compares the 2 different groups of animals. The data were well fitted by a single Boltzmann function. There were no significant changes in the halfinactivation voltages and the maximum slope factors between groups (Figure 4E and 4F To determine whether the observed changes in Na ϩ current density in cardiac hypertrophy and failure are associated with altered kinetics, the time course of inactivation was assessed by biexponential fits to the whole-cell current decay over a range of test potentials from Ϫ50 to Ϫ15 mV. Figure 5A shows examples of the biexponential fits with time constants indicated below the current traces. The increase in the Na ϩ current densities in cardiac hypertrophy and failure was not associated with changes in the time course of inactivation ( Figure 5B ). The time constants of current decay in cells from cardiac hypertrophy and failure animals and the age-matched sham-operated animals overlapped at all potentials. The recovery kinetics were determined at Ϫ80, Ϫ100, and Ϫ120 mV using standard 2-pulse protocols ( Figure 5C through 5E). Repriming of the Na ϩ current in cells isolated from cardiac hypertrophy and failure hearts and control cells was well fitted with single exponential functions. The time constants of the recovery kinetics at all 3 different potentials did not differ between the groups.
Current Densities of L-Type and T-Type Ca
2؉
Current Were Unaltered
The 2 different populations of Ca 2ϩ currents were separated by differences in their steady-state inactivation ( Figure 6 ). Currents were activated from holding potentials of Ϫ90 and Ϫ50 mV using a stimulation frequency of 0.1 Hz. Depolarization from a holding potential of Ϫ50 mV inactivates a small portion of the current, which has a rapid activation and inactivation kinetics, as expected for the T-type current. The T-type Ca 2ϩ currents were then determined by subtraction of traces obtained at a holding potential of Ϫ50 mV from those obtained at a holding potential of Ϫ90 mV. There were no significant differences in the L-or T-type current density between the sham-operated or banded animals at the 2 different time points (4 and 8 weeks, Figure 6 ). However, there was a significant alteration in the inactivation kinetics of the L-type Ca 2ϩ channels in the banded animals ( Figure 7 ). 
Ca
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Figure 5. There were no significant differences in the inactivation kinetics of the Na ϩ currents in the 2 different groups of animals at 2 different time points. A, Examples of Na ϩ current traces at step potentials of Ϫ40 and Ϫ20 mV from a holding potential of Ϫ100 mV obtained from the 2 different groups of animals. The current traces were fitted using 2 exponential functions with the fast and slow time constants ( fast , slow ) as indicated (in ms). B, Summary of the fast and slow Na ϩ current inactivation time constants comparing the 2 different groups of animals at 4 and 8 weeks. Data are meanϮSEM. For each group, No. of cellsϭ5 to 8, and No. of animalsϭ3. C and D, Recovery kinetics at Ϫ80 mV comparing the 2 different groups of animals at 4 and 8 weeks. Recovery kinetics were determined at Ϫ80, Ϫ100, and Ϫ120 mV using standard 2-pulse protocols. Cells were held at Ϫ140 mV. Currents obtained at different recovery intervals were normalized to the maximum currents. Data are meanϮSEM. nϭ6 cells, 3 animals from each group. Data were fitted using a single exponential function (solid lines). Insets show examples of the current traces obtained using the 2-pulse protocols from 2 cells isolated from hypertrophy and heart failure animals, respectively. E, Summary data of time constants of recovery at Ϫ80, Ϫ100, and Ϫ120 mV from the 2 different groups of animals at 4 and 8 weeks. The holding potential used in these experiments was Ϫ140 mV at a frequency of stimulation of 0. Figure 7C ). The Ba 2ϩ currents were well fit using one exponential function ( were 137Ϯ10.9 versus 117Ϯ5.6 ms; PϭNS comparing sham [nϭ9] and banded [nϭ11] animals at 8 weeks). Ca 2ϩ currents recorded in the presence of 10 mmol/L EGTA were well fit using 2 exponential functions. As expected, both f and s were prolonged compared with recordings obtained from low Ca 2ϩ buffering condition. However, there were no significant differences in both f and s between the control and experimental animals; f were 37.1Ϯ3.2 versus 44.2Ϯ4.9, and s were 140.7Ϯ2.6 versus 165Ϯ30.9, PϭNS for sham (nϭ9), as compared with banded (nϭ11) animals at 8 weeks. Similar data were obtained at 4 weeks. These findings are consistent with an attenuation of the Ca 2ϩ -dependent inactivation of the L-type Ca 2ϩ current in this model of cardiac hypertrophy and failure. This decrease in the Ca 2ϩ -dependent inactivation is likely due to the decrease in the sarcoplasmic/endoplasmic reticulum Ca 2ϩ ATPase pumps 13 coupled with a compensatory increase in the Na ϩ -Ca 2ϩ exchanger (Figure 8 ) leading to a decrease in the SR Ca 2ϩ load. Indeed, a depression in the Ca 2ϩ transients as assessed by a Ca 2ϩ indicator dye, Fura-2, has previously been documented in this model. 26 There was a decrease in the peak systolic [Ca 2ϩ ] i in hypertrophy animals with further depression in hypertrophy animals with congestive heart failure compared with the control animals. This depression was associated with a decrease in the time to peak and relaxation of the Ca 2ϩ transients. 26 We tested this prediction further by assessing whether abolishing the SR function (using ryanodine pretreatment) could eliminate the difference in Ca 2ϩ current kinetics observed in our studies. Figure 7D shows the effects of ryanodine pretreatment on the Ca 2ϩ -current inactivation. Ca 2ϩ currents recorded in the presence of 10 mol/L ryanodine were well fit using 2 exponential functions. There were no significant differences in both f and s between the control and experimental animals after ryanodine pretreatment; f were 29.9Ϯ1.5 versus 28.1Ϯ2.7, and s were 125.7Ϯ3.9 versus 136.7Ϯ16.8, PϭNS for sham (nϭ9) as compared with banded (nϭ11) animals at 8 weeks. Action potentials were directly assessed before and after ryanodine in control and experimental animals ( Figure 7E and 7F). Ryanodine prolonged the APD in both control and experimental animals but to a much smaller extent in the banded animals. Importantly, after abolishing the SR function, the APDs were slightly shorter in the banded animals as compared with control, possibly reflecting the increase in the Na ϩ -Ca 2ϩ exchanger function as discussed below (see also Figure 8 ). APDs after ryanodine pretreatment at 50% and 90% repolarization (in ms) were 225Ϯ20 and 246Ϯ15 (nϭ4) for 8-week banded and 261Ϯ24 and 280Ϯ24 (nϭ3) for 8-week sham animals, respectively; PϽ0.05 comparing banded versus sham-operated animals.
Taken together, our data strongly suggest that such attenuation in the Ca 2ϩ -dependent Ca 2ϩ current inactivation is responsible for the observed action potential prolongation. However, other abnormalities (eg, defect in the coupling between L-type Ca 2ϩ channel and the ryanodine release channel) could be invoked to explain the present findings 27 as well.
Na
؉ -Ca 2؉ Exchange Current Is Upregulated in the Cardiac Hypertrophy and Failure Model Na ϩ -Ca 2ϩ exchange current density was measured in banded animals compared with sham-operated controls. Depolarization from a holding potential of Ϫ80 mV to positive membrane potentials elicited declining outward currents. Repolarization back to the holding potential elicited declining inward tail currents. The Ni 2ϩ -sensitive currents (the Na ϩ -Ca 2ϩ exchanger currents 23 ) were determined by subtracting current records obtained during exposure to 5 mmol/L Ni 2ϩ from control traces. Figure 8A shows the Ni 2ϩ -sensitive currents obtained from sham-operated as compared with banded animals at 4 and 8 weeks. Figure 8B shows the significant increase in the peak tail current density after depolarization to ϩ60 mV from animals with compensated hypertrophy and failure as compared with the age-matched sham-operated controls. The corresponding tail current density (in pA/pF) after depolarization to ϩ50 mV was Ϫ2.0Ϯ0.7 versus Ϫ0.8Ϯ0.1 (nϭ5, Pϭ0.01 comparing banded and sham animals at 4 weeks) and Ϫ1.3Ϯ0.1 versus Ϫ0.6Ϯ0.1 (nϭ6, Pϭ0.02 comparing banded and sham animals at 8 weeks). 
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Western blots were used to further establish the level of the Na ϩ -Ca 2ϩ exchanger protein. Figure 8C through 8E shows a significant increase in the exchanger protein level in both hypertrophy and failure animals as compared with controls.
Discussion
One of the problems in the mechanistic studies of human heart failure is the inability to investigate and follow the early and longitudinal changes of the disease process. In this study, we assessed the electrophysiologic changes in a guinea pig model during an early time point of the disease, when the animals develop compensated cardiac hypertrophy, and at a later time point, when congestive heart failure has developed.
We have demonstrated the following. (1) APDs are significantly prolonged during both cardiac hypertrophy and failure as compared with the age-matched control. (2) These changes in the repolarization process are not associated with changes in the K ϩ current density. (3) There is a significant upregulation of the Na ϩ current density and Na The hemodynamic consequences of aortic banding in this model have previously been examined. 13 No significant difference was observed in the basal nonstimulated cardiac functional parameters between the compensated hypertrophic and the respective sham-operated control animals. In contrast, contractility, developed pressure, speed of relaxation, normalized time-to-peak pressure, and normalized time to halfrelaxation were depressed significantly in banded animals at 8 weeks.
Mechanisms of Action Potential Prolongation in Cardiac Hypertrophy and Failure
One single most consistent abnormality found in animal models of cardiac hypertrophy and failure models is APD prolongation. 4, 5, [7] [8] [9] Prolongation of APD may occur secondary to an increase in the depolarizing currents and/or a decrease in the repolarizing currents. We and others have previously shown that downregulation of I to and I K1 underlie action potential prolongation in cardiac hypertrophy and failure models. 8 -10,28,29 Guinea pig ventricles do not express I to ; however, we find changes in APD that are similar to those in previous studies of cardiac failure models. We have demonstrated in the present study that the cellular electrophysiological changes that accompany the action potential prolongation in this guinea pig model involve Ca 2ϩ handling processes and are different from the predominant abnormalities in K ϩ currents that are found in animal models that express I to . Thus, this study challenges one of the assumptions in the field of cardiac hypertrophy and failure, namely that the common phenotype of hypertrophy and failure implies common underlying mechanisms.
Results from studies of changes in Ca 2ϩ current in cardiac hypertrophy and failure models vary. Whereas some studies have reported a decrease in the Ca 2ϩ current, 30, 31 others showed a significant increase 18, 32 ; still others showed no change in the Ca 2ϩ current. 9, [33] [34] [35] These disparities are due in part to the differences in the models used. 30 In addition, the incongruity of the results from previous studies may result from variation in the experimental conditions. For example, Ca 2ϩ currents are frequently measured using high concentrations of Ca 2ϩ chelators, which may mask the changes in the kinetics of the Ca 2ϩ current associated with cardiac hypertrophy and failure. By using 50 mol/L BAPTA, which is a high enough concentration to allow stable Ca 2ϩ current recordings but substantially low to reduce the effects of exogenous Ca 2ϩ chelators on intracellular Ca 2ϩ handling, we observed marked differences between the inactivation kinetics of the L-type Ca 2ϩ current in cardiac hypertrophy and failure animals as compared with age-matched control animals.
Interdependence of Ca 2؉ Handling and Membrane Currents in Cardiac Hypertrophy and Failure Models
In contrast to other models of cardiac failure, which show a significant downregulation of I to and I K1 , there are no significant changes in I K1 , I Kr , and I Ks in the guinea pig model during hypertrophy and failure stages. We propose an alternate 2ϩ currents recorded in the presence of 10 mmol/L EGTA were well fit using 2 exponential functions. As expected, both f and s were prolonged compared with recordings obtained under low Ca 2ϩ buffering conditions. However, there were no significant differences in both f and s between the control and experimental animals: f were 37.1Ϯ3.2 vs 44.2Ϯ4.9, and s were 140.7Ϯ2.6 vs 165Ϯ30.9, PϭNS, for sham (nϭ9) as compared with banded (nϭ11) animals at 8 weeks. Similar data were obtained at 4 weeks. D, Ryanodine (RY) pretreatment eliminated the difference in Ca 2ϩ current kinetics between banded and sham animals. Ca 2ϩ currents were well fit using 2 exponential functions. There were no significant differences in both f and s between the control and experimental animals after ryanodine pretreatment; f were 29.9Ϯ1.5 vs 28.1Ϯ2.7, and s were 125.7Ϯ3.9 vs 136.7Ϯ16.8, PϭNS for sham (nϭ9) as compared with banded (nϭ11) animals at 8 weeks. E and F, Action potentials were recorded before and after ryanodine in control and experimental animals at 8 weeks. Ryanodine prolonged the APD in both control and experimental animals but to a much smaller extent in banded animals. After abolishing the SR function, the APDs were slightly shorter in the banded animals as compared with controls, possibly reflecting the increase in the Na 
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mechanism of action potential prolongation in this guinea pig model of hypertrophy and failure, which is dependent on changes in Ca 2ϩ cycling proteins. There is a significant downregulation of the SR Ca 2ϩ -ATPase protein level (85% of the control) and phospholamban (65% of the control), 13 coupled with a significant upregulation of the Na 26 This decrease in the peak systolic [Ca 2ϩ ] i was associated with a decrease in the time to peak and relaxation of the Ca 2ϩ transient. 26 In addition, previous studies have shown a close interaction between SR Ca 2ϩ load and Ca 2ϩ -dependent inactivation of the L-type Ca 2ϩ channel. 36 -41 The present findings are consistent with a theoretical model, which predicts that alteration of the Ca 2ϩ cycling proteins leads to a decrease in the Ca 2ϩ -dependent inactivation of the L-type Ca 2ϩ channels. 42 Under the normal modulatory role of intracellular Ca 2ϩ , changes in Ca 2ϩ cycling proteins have greater effects on the APD than the downregulation of I to . 42 The reduction of I to leads to a significant prolongation of the APD only under conditions of exogenous intracellular Ca 2ϩ buffering, which masks the modulatory effects of Ca 2ϩ and enhances the influence of the outward K ϩ current. 42, 43 By recording action potential using a perforated patch, we expect the modulatory role of the endogenous intracellular Ca 2ϩ to be operable. We have found a compensatory upregulation of the Na ϩ -Ca 2ϩ exchange current and the protein level. Similar changes in the exchanger levels have previously been shown in a canine tachycardia-induced heart failure and human heart failure. 16, [43] [44] [45] This alternate Ca 2ϩ removal system by Na ϩ -Ca 2ϩ exchanger may compensate for the defective SR Ca 2ϩ uptake. In addition, the enhanced Ca 2ϩ entry via the reverse mode of the Na ϩ -Ca 2ϩ exchanger may provide inotropic support for the failing myocytes. 44 Because the exchanger is electrogenic, it also plays a significant role in the action potential profile. The increase in the exchanger current alone may shorten the APD; however, these changes may be counteracted by the increase in the inward Ca 2ϩ currents. 42 Upregulation of the Na ؉ Current Density Na ϩ current density was significantly increased during cardiac hypertrophy and failure, but there were no changes in the steady-state activation and inactivation kinetics. The exact Figure 8 . Na ϩ -Ca 2ϩ exchange currents and protein level are significantly increased in hypertrophy and heart failure animals. Ionic currents, which interfere with the measurement of Na ϩ -Ca 2ϩ exchange current, were blocked using Cs ϩ and tetrodotoxin. Entry of Ca 2ϩ through the L-type Ca 2ϩ channel and release of Ca 2ϩ from SR were blocked using nifedipine and ryanodine, respectively. A, Examples of Ni 2ϩ -sensitive Na ϩ -Ca 2ϩ exchange currents during 1.5-second depolarizing pulses from a holding potential of Ϫ80 to Ϫ20 to ϩ60 mV. Ni 2ϩ -sensitive currents were obtained by subtracting current records after exposure to 5 mmol/L Ni 2ϩ from control records. B, Summary data of the peak tail current density (normalized to the cell capacitance) obtained after the depolarization step to ϩ60 mV back to Ϫ80 mV showing the significant increase in peak tail current density of Ni 2ϩ -sensitive currents in hypertrophy and heart failure animals. Data are meanϮSEM. *Pϭ0.009, #Pϭ0.03, nϭ5 to 6 cells and 3 animals each from sham and banded groups at 4 and 8 weeks, respectively. C and D, Western blots showing densities of Na ϩ -Ca 2ϩ exchanger protein (NCX) (C) from 3 different experiments (a, b, and c) from shamoperated animals at 4 and 8 weeks compared with banded animals at 4 and 8 weeks and protein level of actin and calsequestrin (D). Actin was used as internal control to normalize for the Na ϩ -Ca 2ϩ exchanger protein. E, Summary data for the relative Na ϩ -Ca 2ϩ exchanger protein level normalized to the actin level from 3 different groups of animals (nϭ6 for each group, *PϽ0.001).
mechanisms of this upregulation are not known. However, such changes may arise from an increase in the channel biosynthesis resulting from changes in the intracellular Ca 2ϩ , as previously reported. 46 -48 The amplitude of the Ca 2ϩ transient is depressed in several models of cardiac hypertrophy and failure, including this guinea pig model. 26,43,49 -51 Changes in Na ϩ current density have been documented in different in vivo animal models. There was a significant reduction in the Na ϩ current density in cardiac myocytes isolated from the epicardial border zone surrounding the infarcted area as compared with the normal zone in infarcted canine hearts, which may result from intracellular Ca 2ϩ overload in the cardiac myocytes in these cells. 52 Similarly, alteration of Na ϩ channel expression has been demonstrated in a dog model of atrial fibrillation. 53 These data suggest that Na ϩ channel expression may be tightly regulated by changes in intracellular Ca 2ϩ . Finally, the present study indicates that changes that occur during cardiac hypertrophy parallel those that occur during the later stage when heart failure has developed. Evaluation at an even earlier time point may be necessary to follow the progression from cardiac hypertrophy to failure. The present study suggests a continuum of changes in the action potential characteristic and the level of the Ca 2ϩ cycling proteins in this model of cardiac hypertrophy and failure. There is a strong interdependence between the abnormality in Ca 2ϩ cycling proteins found in cardiac hypertrophy and failure and the electrophysiologic changes in these states.
